| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Total adjusted ebitda | 10,146 | - |
| Interest expense, interest and dividend income and other expenses | 16,939 | - |
| Depreciation and amortization | 13,741 | - |
| Amortization of lease intangible | 540 | - |
| Benefit (provision) for income taxes | -25 | - |
| Stock-based compensation | 25,985 | - |
| Payroll tax expense related to stock-based compensation | 2,100 | - |
| Acquisition and other | 927 | - |
| Charitable contribution of common stock | 2,080 | - |
| Income from unconsolidated joint venture | 544 | - |
| Impairment of assets | 49 | - |
| Restructuring charges | 1,464 | - |
| Net loss | -53,110 | -41,513 |
| Depreciation and amortization | 13,741 | 8,741 |
| Impairment of assets | 49 | - |
| Reduction in carrying amount of right-of-use asset | 3,350 | 2,212 |
| Lease termination | 14 | 30 |
| Stock based compensation | 25,985 | 15,237 |
| Revaluation of contingent consideration | 0 | 0 |
| Income from unconsolidated joint venture | 144 | 90 |
| Donation of common stock | 2,080 | 1,130 |
| Loss on debt extinguishment | -16,430 | -16,430 |
| Gain on sale of property and equipment | 0 | 0 |
| Amortization of deferred costs on convertible notes | 1,527 | 937 |
| Deferred tax benefit | -44 | -23 |
| Accounts receivable, net | 23,370 | 13,505 |
| Inventory | 192 | 572 |
| Prepaid expenses | 904 | 118 |
| Other assets | 1,233 | 59 |
| Accounts payable and accrued cost of revenue | 10,728 | 6,361 |
| Other accrued expenses | 9,100 | 1,994 |
| Contract liabilities | 3,170 | 2,050 |
| Lease liabilities | -5,202 | -3,170 |
| Other liabilities | -24 | -22 |
| Income taxes payable | -249 | -108 |
| Net cash provided by (used in) operating activities | 1,674 | -4,118 |
| Purchases of marketable securities | 6,571 | 4,438 |
| Proceeds from sale of marketable securities | 20,500 | 13,000 |
| Distributions in excess of earnings | - | 66 |
| Purchases of property and equipment | 19,911 | 12,462 |
| Proceeds from sale of property and equipment | 0 | 0 |
| Net cash used in investing activities | -5,982 | -3,834 |
| Proceeds from issuance of convertible notes | 250,000 | 250,000 |
| Costs incurred in connection with issuance of convertible notes | 8,650 | 7,822 |
| Payments for repurchase of convertible notes | 215,992 | 215,992 |
| Purchase of capped calls | 17,475 | 17,475 |
| Purchase of treasury stock | 8,080 | 8,080 |
| Proceeds from stock options exercised | 2,703 | 1,415 |
| Net cash provided by financing activities | 2,506 | 2,046 |
| Effect of foreign currency translation on cash and cash equivalents | 415 | 425 |
| Net decrease in cash and cash equivalents | -1,387 | -5,481 |
| Cash and cash equivalents at beginning of period | 22,232 | - |
| Cash and cash equivalents at end of period | 20,845 | - |
Xometry, Inc. (XMTR)
Xometry, Inc. (XMTR)